Apyx Medical Corporation APYX Noncontrolling interests in subsidiaries
Noncontrolling interests in subsidiaries at other companies
Other financials
Where this comes from
Reported directly by Apyx Medical Corporation in its filing.
Tagged under the XBRL concept us-gaap:MinorityInterest.
The official record: Apyx Medical Corporation’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Apyx Medical Corporation's noncontrolling interests in subsidiaries.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Apyx Medical Corporation's noncontrolling interests in subsidiaries?
- Apyx Medical Corporation (APYX) reported noncontrolling interests in subsidiaries of $256K in Q1 2026.
- How has Apyx Medical Corporation's noncontrolling interests in subsidiaries changed year-over-year?
- Apyx Medical Corporation's noncontrolling interests in subsidiaries increased by 92.5% year-over-year, from $133K to $256K.
- What is the long-term trend for Apyx Medical Corporation's noncontrolling interests in subsidiaries?
- Over 5 years (2020 to 2025), Apyx Medical Corporation's noncontrolling interests in subsidiaries has grown at a 16.1% compound annual growth rate (CAGR), from $138K to $291K.
- What does noncontrolling interests in subsidiaries mean?
- This represents the portion of a subsidiary's net assets that is owned by outside shareholders rather than the parent company. It is reported within equity to show the total value of the subsidiary's assets and liabilities that are not attributable to the parent. It reflects the non-controlling stake in consolidated entities.